Clinitech Laboratory Ratios

Clinitech Laboratory Ltd Ratios

The Clinitech Laboratory Ltd Ratios page provides a complete fundamental analysis of Clinitech Laboratory Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Clinitech Laboratory Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Clinitech Laboratory Ltd (NSE: , BSE: 544220) is currently trading at ₹32.82, with a market capitalization of ₹0. As a major player in the Health services sector and Medical/Nursing services industry, Clinitech Laboratory Ltd remains a key stock for fundamental analysis using Clinitech Laboratory Ltd Ratios.

Clinitech Laboratory Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Clinitech Laboratory Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Clinitech Laboratory Ltd Ratios.

Historically, the Clinitech Laboratory Ltd P/E ratio has shown strong fluctuations:

The decline in Clinitech Laboratory Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Clinitech Laboratory Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Clinitech Laboratory Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Clinitech Laboratory Ltd P/S ratio currently stands at 0, an important part of Clinitech Laboratory Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Clinitech Laboratory Ltd P/S ratio indicates cautious market sentiment.

Clinitech Laboratory Ltd Price to Cash Flow Ratio (P/CF)

The Clinitech Laboratory Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Clinitech Laboratory Ltd Price to Cash Flow Ratio:

The declining Clinitech Laboratory Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Clinitech Laboratory Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Clinitech Laboratory Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Clinitech Laboratory Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Clinitech Laboratory Ltd EV/EBITDA ratio is currently 0, a key metric in Clinitech Laboratory Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Clinitech Laboratory Ltd EV/EBITDA indicates balanced valuation.

Clinitech Laboratory Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Clinitech Laboratory Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Clinitech Laboratory Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Clinitech Laboratory Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Clinitech Laboratory Ltd Ratios Analysis Summary

The Clinitech Laboratory Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Clinitech Laboratory Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Clinitech Laboratory Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.